Notice of Extension of the Expiration Date for PAR-23-059 "National Cancer Institute Program Project Applications for the Years 2023, 2024, and 2025 (P01 Clinical Trial Optional)"

About this opportunity

The purpose of this Notice is to extend the expiration date for PAR-23-059, National Cancer Institute Program Project Applications for the Years 2023, 2024, and 2025 (P01 Clinical Trial Optional). Therefore, with the addition/extension by one Application Due Date, PAR-23-059 now expires on September 8, 2026. The following sections in Part 1. Overview Information, Key Dates section have been changed: Referral OfficerNational Cancer Institute (NCI)Telephone: 240-276-6390Email: [email protected]